A neuropsychological study comparing patients infected with HCV and HBV without psychiatric comorbidities

Journal of Medical Virology

Volumn 81, Issue 7, 2009, Pages 1184-1188

  Quarantini, Lucas C ^a,b,g   Miranda Scippa, Angela ^a   Batista Neves, Susana ^a   Powell, Vania B ^a   Abreu, Neander ^a   Abreu, Katiusha C ^a   Moura, Ilka ^a   Crane, Jacquelyn ^c   Sampaio, Aline S ^d   Netto, Liana R ^a   DeOliveira, Irismar R ^a   Paraná, Raymundo ^a   Bressan, Rodrigo A ^b   Lacerda, Acioly L T ^b,e,f  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c HARVARD UNIVERSITY   (United States)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e Instituto Sinapse de Neurocie ncias Clínicas   (Brazil)

^f Centro de Pesquisa e Ensaios Clínicos Sinapse Bairral   (Brazil)

^g NONE   (Brazil)

Author keywords

Chronic liver disease; Cognitive dysfunction; Hepatitis C virus; Major depression; Mental disorders

Indexed keywords

ADULT; ARTICLE; COGNITIVE DEFECT; COMORBIDITY; DEPTH PERCEPTION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; NONHUMAN; ADOLESCENT; AGED; CENTRAL NERVOUS SYSTEM DISEASE; COMPARATIVE STUDY; MEMORY DISORDER; MIDDLE AGED;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

ADOLESCENT; ADULT; AGED; CENTRAL NERVOUS SYSTEM DISEASES; COGNITION DISORDERS; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; MALE; MEMORY DISORDERS; MIDDLE AGED; YOUNG ADULT;

EID: 67649995294     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21508     Document Type: Article

References (55)

1. Albus M, Hubmann W, Wahlheim C, Sobizack N, Franz U, Mohr F. 1996. Contrasts in neuropsychological test profile between patients with first-episode schizophrenia and first-episode affective disorders. Acta Psychiatr Scand 94:87-93. (Pubitemid 26294859)
2. American Psychiatric Association. editor. 2000. Diagnostic and statistical manual of mental disorders. 4th edition, Text Revision ed. Washington, DC: American Psychiatric Press.
3. Amorim P. 2000. Mini International Neuropsychiatric Interview (MINI): Validação de entrevista breve para diagnóstico de transtornos mentais. Revista Brasileira de Psiquiatria 22:106-115.
4. Armstrong GL, Alter MJ, McQuillan GM, Margolis HS. 2000. The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States. Hepatology 31:777-782. (Pubitemid 30118650)
5. Basso MR, Bornstein RA. 1999. Relative memory deficits in recurrent versus first-episode major depression on a word-list learning task. Neuropsychology 13:557-563. (Pubitemid 29474644)
6. Batista-Neves SC, Quarantini LC, de Almeida AG, Bressan RA, Lacerda AL, de-Oliveira IR, Parana R, Miranda-Scippa A. 2008. High frequency of unrecognized mental disorders in HCV-infected patients. Gen Hosp Psychiatry 30:80-82.
7. Bulbena A, Berrios GE. 1993. Cognitive function in the affective disorders: A prospective study. Psychopathology 26:6-12. (Pubitemid 23146384)
8. Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM. 1996. Immunoregulatory cytokines in chronic hepatitis C virus infection: Pre- and posttreatment with interferon alfa. Hepatology 24:6-9. (Pubitemid 26249404)
9. Coello E, Ardila A, Rosselli M. 1990. Is there a cognitive marker in major depression? Int J Neurosci 50:137-145.
10. Collie A. 2005. Cognition in liver disease. Liver Int 25:1-8.
11. Diniz LFM, Cruz MF, Torres V, Cosenza RM. 2000. O teste de aprendizagem auditivo-verbal de Rey: Normas para uma população brasileira. Rev Bras Neurol 36:79-83.
12. Dunkin JJ, Leuchter AF, Cook IA, Kasl-Godley JE, Abrams M, Rosenberg-Thompson S. 2000. Executive dysfunction predicts nonresponse to fluoxetine in major depression. J Affect Disord 60: 13-23. (Pubitemid 30625240)
13. el-Serag HB, Kunik M, Richardson P, Rabeneck L. 2002. Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology 123:476-482.
14. Ersche KD, Fletcher PC, Lewis SJ, Clark L, Stocks-Gee G, London M, Deakin JB, Robbins TW, Sahakian BJ. 2005. Abnormal frontal activations related to decision-making in current and former amphetamine and opiate dependent individuals. Psychopharmacology (Berl) 180:612-623. (Pubitemid 41317858)
15. Farkkila M, IivanainenM, Roine R, Bergstrom L, Laaksonen R, Niemi ML, Cantell K. 1984. Neurotoxic and other side effects of high-dose interferon in amyotrophic lateral sclerosis. Acta Neurol Scand 70: 42-46. (Pubitemid 14085619)
16. Fontana RJ, Bieliauskas LA, Back-Madruga C, Lindsay KL, Kronfol Z, Lok AS, Padmanabhan L. 2005. Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial. J Hepatol 43:614-622. (Pubitemid 41253228)
17. Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor- Robinson SD. 2001. Evidence for a cerebral effect of the hepatitis C virus. Lancet 358:38-39. (Pubitemid 32709741)
18. Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, Main J, Wesnes KA, Taylor-Robinson SD. 2002. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 35:433-439. (Pubitemid 34106386)
19. Henriques JB, Davidson RJ. 1997.Brain electrical asymmetries during cognitive task performance in depressed and nondepressed subjects. Biol Psychiatry 42:1039-1050. (Pubitemid 27496435)
20. Hilsabeck RC, Perry W, Hassanein TI. 2002. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology 35:440-446. (Pubitemid 34106387)
21. Hilsabeck RC, Hassanein TI, Carlson MD, Ziegler EA, Perry W. 2003. Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. J Int Neuropsychol Soc 9:847-854. (Pubitemid 37139014)
22. Kronfol Z, Remick DG. 2000. Cytokines and the brain: Implications for clinical psychiatry. Am J Psychiatry 157:683-694. (Pubitemid 30249643)
23. LandroNI, Stiles TC, Sletvold H. 2001.Neuropsychological function in nonpsychotic unipolar major depression.Neuropsychiatry Neuropsychol Behav Neurol 14:233-240.
24. Lee BN, Dantzer R, Langley KE, Bennett GJ, Dougherty PM,Dunn AJ, Meyers CA, Miller AH, Payne R, Reuben JM, Wang XS, Cleeland CS. 2004. A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation 11:279-292. (Pubitemid 39194326)
25. Licinio J, Kling MA, Hauser P. 1998. Cytokines and brain function: Relevance to interferon-alpha-induced mood and cognitive changes. Semin Oncol 25:30-38. (Pubitemid 28093153)
26. Mattarozzi K, Campi C, GuarinoM, Stracciari A. 2005. Distinguishing between clinical and minimal hepatic encephalopathy on the basis of specific cognitive impairment. Metab Brain Dis 20:243-249. (Pubitemid 41355614)
27. McAndrews MP, Farcnik K, Carlen P, Damyanovich A, Mrkonjic M, Jones S, Heathcote EJ. 2005. Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. Hepatology 41:801-808. (Pubitemid 40462942)
28. McHutchison JG. 2004. Understanding hepatitis C. Am J Manag Care 10:S21-S29.
29. Merriam EP, Thase ME, Haas GL, Keshavan MS, Sweeney JA. 1999. Prefrontal cortical dysfunction in depression determined by Wisconsin Card Sorting Test performance. Am J Psychiatry 156: 780-782. (Pubitemid 29220082)
30. Meyers JE, Bayless JD, Meyers KR. 1996. Rey complex figure: Memory error patterns and functional abilities. Appl Neuropsychol 3:89-92. (Pubitemid 126729123)
31. Meyers CA, Albitar M, Estey E. 2005. Cognitive impairment, fatigue, and cytokine levels in patients with acutemyelogenous leukemia or myelodysplastic syndrome. Cancer 104:788-793. (Pubitemid 41113679)
32. Murray J, Fishman SL, Ryan E, Eng FJ, Walewski JL, Branch AD, Morgello S. 2008. Clinicopathologic correlates of hepatitisCvirus in brain: A pilot study. J Neurovirol 14:17-27. (Pubitemid 351314970)
33. Pan W, Kastin AJ, Bell RL, Olson RD. 1999. Upregulation of tumor necrosis factor alpha transport across the blood-brain barrier after acute compressive spinal cord injury. J Neurosci 19:3649-3655. (Pubitemid 29203143)
34. Pantiga C, Rodrigo LR, Cuesta M, Lopez L, Arias JL. 2003. Cognitive deficits in patients with hepatic cirrhosis and in liver transplant recipients. J Neuropsychiatry Clin Neurosci 15:84-89. (Pubitemid 36168085)
35. Perry W, Hilsabeck RC, Hassanein TI. 2008. Cognitive dysfunction in chronic hepatitis C: A review. Dig Dis Sci 53:307-321. (Pubitemid 351170036)
36. Porter RJ, Gallagher P, Thompson JM, Young AH. 2003. Neurocognitive impairment in drug-free patients with major depressive disorder. Br J Psychiatry 182:214-220. (Pubitemid 36286734)
37. Purcell R, Maruff P, Kyrios M, Pantelis C. 1997. Neuropsychological function in young patients with unipolar major depression. Psychol Med 27:1277-1285. (Pubitemid 27494093)
38. Purcell R, Maruff P, Kyrios M, Pantelis C. 1998. Neuropsychological deficits in obsessive-compulsive disorder: A comparison with unipolar depression, panic disorder, and normal controls. Arch Gen Psychiatry 55:415-423. (Pubitemid 28237275)
39. Quarantini LC, Miranda-Scippa A, Rocha M, Bressan RA. 2008. Neuropsychological function in patients with chronic hepatitis C. Liver Int 28:893-894; author reply 894-895. (Pubitemid 351818655)
40. Reitan RM. 1992. Trial making test: Manual for administration and scoring. South Tucson, AZ: Reintan Neuropsychology Laboratory.
41. Rosenbloom MJ, O'Reilly A, Sassoon SA, Sullivan EV, Pfefferbaum A. 2005. Persistent cognitive deficits in community-treated alcoholic men and women volunteering for research: Limited contribution from psychiatric comorbidity. J Stud Alcohol 66:254-265.
42. Saunders JC. 2008. Neuropsychiatric symptoms of hepatitis C. Issues Ment Health Nurs 29:209-220.
43. Schatzberg AF, Posener JA, DeBattista C, Kalehzan BM, Rothschild AJ, Shear PK. 2000. Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness. Am J Psychiatry 157:1095-1100. (Pubitemid 30432490)
44. ShelineYI. 2000. 3D MRI studies of neuroanatomic changes inunipolar major depression: The role of stress and medical comorbidity. Biol Psychiatry 48:791-800.
45. ShepardCW,Finelli L, Alter MJ.2005. Global epidemiology ofhepatitis C virus infection. Lancet Infect Dis 5:558-567. (Pubitemid 41196755)
46. Shibata M, Blatteis CM. 1991. Human recombinant tumor necrosis factor and interferon affect the activity of neurons in the organum vasculosum laminae terminalis. Brain Res 562:323-326.
47. Sweeney JA, Kmiec JA, Kupfer DJ. 2000. Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery. Biol Psychiatry 48:674-684. (Pubitemid 30734236)
48. Thein HH, Maruff P,Krahn MD, Kaldor JM, Koorey DJ, Brew BJ,Dore GJ. 2007. Improved cognitive function as a consequence of hepatitis C virus treatment. HIV Med 8:520-528. (Pubitemid 47616831)
49. Wechsler D. 1997.Wechsler adult intelligence scale. San Antonio, TX: Psychological Corporation.
50. Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H. 2001. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34:768-773.
51. Weissenborn K, Krause J, Bokemeyer M, Hecker H, Schuler A, Ennen JC, Ahl B, Manns MP, Boker KW. 2004. Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol 41:845-851. (Pubitemid 39434316)
52. Weissenborn K, Bokemeyer M, Krause J, Ennen J, Ahl B. 2005. Neurological and neuropsychiatric syndromes associated with liver disease. AIDS 19:S93-S98. (Pubitemid 41682175)
53. Wilson CJ, Finch CE, Cohen HJ. 2002. Cytokines and cognition-The case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc 50:2041-2056. (Pubitemid 35462453)
54. Wrona D. 2006. Neural-immune interactions: An integrative view of the bidirectional relationship between the brain and immune systems. J Neuroimmunol 172:38-58. (Pubitemid 43277489)
55. Yovtcheva SP, Rifai MA, Moles JK, Van der Linden BJ. 2001. Psychiatric comorbidity among hepatitis C-positive patients. Psychosomatics 42:411-415. (Pubitemid 33032113)